Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Additional Listing

10 May 2019 13:30

RNS Number : 6536Y
Coca-Cola European Partners plc
10 May 2019
 

Date: 10 May 2019

Coca-Cola European Partners plc

Additional Listing

Coca-Cola European Partners plc (the 'Company') has issued and allotted 746,026 new ordinary shares of €0.01 each (the "Shares") under two employee share schemes: (1) the Coca-Cola Enterprises, Inc. 2010 Incentive Award Plan; and (2) the Coca-Cola Enterprises, Inc. Legacy Long-Term Incentive Plan.

Accordingly, an application has been made to the Financial Conduct Authority for the Shares to be admitted to listing on the Official List and to the London Stock Exchange (the "LSE") for the Shares to be admitted to trading on the Main Market of the LSE. The Shares will rank pari passu with the existing shares of the Company.

Admission of the Shares is expected on 13 May 2019.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSGGUAGAUPBUMU
Date   Source Headline
12th Dec 20244:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:45 pmRNSTotal Voting Rights
21st Nov 202411:00 amRNSDirector/PDMR Shareholding
18th Nov 20242:00 pmRNSUpdate statement on 2024 AGM voting results
15th Nov 20248:01 amRNSTransfer to ESCC Category
5th Nov 20243:30 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSQ3 Trading Update & Interim Dividend Declaration
1st Nov 20241:31 pmRNSTotal Voting Rights
24th Oct 20243:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20243:00 pmRNSDirector/PDMR Shareholding
18th Oct 20247:00 amRNSIntention to Transfer to ESCC Category
1st Oct 20241:00 pmRNSTotal Voting Rights
25th Sep 202412:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
18th Sep 20243:30 pmRNSDirector/PDMR Shareholding
18th Sep 20243:30 pmRNSBlock listing Interim Review
10th Sep 20244:00 pmRNSDirector/PDMR Shareholding
6th Sep 20244:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20242:00 pmRNSTotal Voting Rights
27th Aug 202411:13 amRNSDirector/PDMR Shareholding
20th Aug 20242:30 pmRNSDirector/PDMR Shareholding
7th Aug 20247:00 amRNSResults for the six months ended 28 June 2024
1st Aug 20242:00 pmRNSTotal Voting Rights
24th Jul 20241:30 pmRNSDirector/PDMR Shareholding
22nd Jul 20241:30 pmRNSDirector/PDMR Shareholding
17th Jul 202412:15 pmRNSDirector/PDMR Shareholding
1st Jul 20241:45 pmRNSTotal Voting Rights
21st Jun 20241:00 pmRNSDirector/PDMR Shareholding
5th Jun 20245:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20242:45 pmRNSTotal Voting Rights
28th May 20241:15 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSAppointment of Chief Financial Officer
22nd May 20244:02 pmRNSResult of AGM
21st May 20241:30 pmRNSDirector/PDMR Shareholding
10th May 20247:00 amRNSLetter to Shareholders
3rd May 20247:00 amRNSResignation of Chief Financial Officer
1st May 20243:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 Trading Update & Interim Dividend Declaration
24th Apr 20241:30 pmRNSDirector/PDMR Shareholding
17th Apr 20241:45 pmRNSDirector/PDMR Shareholding
10th Apr 20249:15 amRNSNotice of AGM
2nd Apr 20242:30 pmRNSTotal Voting Rights
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
20th Mar 20243:00 pmRNSDirector/PDMR Shareholding
18th Mar 20244:30 pmRNSBlock listing Interim Review
15th Mar 202411:59 amRNSAnnual Financial Report
1st Mar 20242:00 pmRNSTotal Voting Rights
23rd Feb 20247:00 amRNSCompletion of joint acquisition of CCBPI
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.